Citius Pharmaceuticals - Articles and news items

Citius initiates Phase 3 Trial to salvage infected central venous catheters

Industry news / 20 September 2016 / Niamh Louise Marriott, Digital Content Producer

Mino-Lok is being developed as an adjunctive therapy for the treatment of catheter-related or central line associated bloodstream infection (CRBSI/CLABSI)…

Citius announces Phase 2a data for haemorrhoid treatment

Industry news / 2 February 2016 / Victoria White

Citius is aiming for its combination cream to become the first FDA-approved prescription product to treat haemorrhoids in the US…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+